Description
The AFB Susceptibility test for first-line drugs evaluates the effectiveness of four primary antibiotics used to treat mycobacterial infections, particularly tuberculosis. This test is essential for determining the most appropriate treatment regimen for patients infected with Mycobacterium tuberculosis or other mycobacteria. By assessing the organism’s susceptibility to these drugs, healthcare providers can tailor the treatment plan to ensure the most effective therapy while minimizing the risk of developing drug resistance. The results of this test play a crucial role in managing tuberculosis and other mycobacterial infections effectively.
Reviews
There are no reviews yet.